Scientists have achieved first-ever successful treatment for one of the most devastating genetic diseases, Huntington’s in a recent medical breakthrough. In the pivotal research study, ...
AMT-130 was generally well-tolerated, with a manageable safety profile at both doses. As of June 30, 2025, no new drug-related serious adverse events have been observed since December 2022. The most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback